Bangladesh's Measles Crisis: A Vaccine Drive That Failed to Save Lives

When Vaccines Fall Short

One-year-old Saif Hasan died in the intensive care unit of Dhaka's Infectious Diseases Hospital (IDH) within minutes of being admitted. His family, like many others, believed the vaccine he had received was to blame for his illness. But as Shrebash Paul, a junior consultant at IDH, explained, it wasn't the vaccine that caused his death—it was the underlying condition that made him vulnerable to measles. The virus had already taken hold.

This tragic case is emblematic of a larger crisis. Bangladesh has administered nearly 20 million measles vaccines since April, yet more than 1,000 children have died from the disease in just a few months. It's a sobering reminder that public health efforts can fail not just due to lack of resources—but also due to faulty planning, misinformation, and deep-rooted systemic issues.

"The infection then aggravated his underlying condition," said Paul, echoing concerns shared by public health experts across the country. "We're dealing with an outbreak that has exposed weaknesses in our immunization system."

This isn't a new problem for Bangladesh. Years of declining vaccination rates, political instability, and disruptions caused by the pandemic have left millions of children vulnerable to diseases like measles, which remains one of the world's most contagious pathogens.

A Target That Was Too Low

Bangladesh's struggle against this outbreak isn't just about numbers—it's a matter of precision. The government's original target for the measles-rubella vaccination campaign was approximately 18 million children aged six months to under five years. By June, however, the campaign had been expanded to include an additional 6 million children in the same age group—bringing the total to nearly 20 million.

This discrepancy reveals a critical flaw in how national coverage goals were calculated. According to Mushtuq Hussain, a former principal scientific officer at Bangladesh's Institute of Epidemiology, Disease Control and Research (IEDCR), population estimates used to set targets may have significantly underestimated the number of children who needed protection.

"You can't just look at national averages," Hussain emphasized. "Equity must be maintained across all communities—including those that are hard-to-reach or mobile."

The numbers alone don't tell the whole story. While Bangladesh reports nearly 20 million doses administered, the distribution of those vaccines—and whether they reached children who were truly susceptible—remains an open question. The same data shows that over 900 suspected measles deaths have been recorded, with only about 100 confirmed by laboratory testing.

Numbers That Can Hide the Real Problem

Measles is not just a disease—it's a signal of broader public health failure. It thrives in environments where immunity gaps exist, and even small pockets of unvaccinated individuals can sustain transmission chains. The fact that nearly 90% of those who have died were under 15 months old—and largely unvaccinated—highlights how critical early protection is.

Paul at IDH told me that most measles patients currently admitted are children who never received the vaccine in the first place. Some missed it because they were sick during vaccination campaigns; others simply weren't reached due to logistical challenges or community distrust.

As a doctor treating these cases, Paul sees firsthand how the system has failed. "The vaccination campaign worked to reduce case numbers," he said, "but the gaps remain.",

One of the most disturbing aspects of this outbreak is that children under nine months—too young for routine vaccination—are now dying from measles infections. This means they were likely infected in utero or during early childhood, before their immune systems could develop resistance.

The Cost of Delayed Action

Political upheaval following the July 2024 uprising played a major role in disrupting the vaccination rollout. New leadership led to delays in vaccine procurement and a temporary halt in routine immunization programs. These interruptions had long-term consequences.

Bangladesh's Coverage Evaluation Survey from 2023 showed that first-dose measles-rubella coverage dropped from 88.6% in 2019 to 86% in 2023, while second-dose coverage fell from 89% to 80.7%. The pandemic further eroded these efforts.

UNICEF cited misinformation and vaccine hesitancy as contributing factors to low vaccination rates. But even more concerning is the failure to act swiftly when signs of a potential outbreak began appearing in early 2026. Cases rose sharply in January, peaked by March, and by April, Bangladesh had officially notified the World Health Organization (WHO) of a nationwide outbreak.

By mid-April, measles cases had been reported in 58 of the country's 64 districts. Yet, even with emergency measures underway, the virus spread faster than expected. What followed was a frantic effort to vaccinate children before it was too late—but it wasn't enough.

The Human Cost Behind the Stats

For every reported death, there are countless stories of grief, fear, and missed opportunities. Mostakim, a nine-month-old from Kishoreganj district, died in August at IDH after not receiving his measles vaccine. His story is just one among many that point to the tragic human cost of delayed responses and flawed planning.

At the hospital, staff are working overtime treating cases—many involving infants too young for routine immunization. Their analysis shows that 83% of those who died had received no vaccine at all, and pneumonia was the most common complication. These findings underscore a critical point: we're not just talking about numbers—we're talking about real lives lost to preventable disease.

The data from IDH shouldn't be seen as nationally representative—but it's still instructive. It gives us a glimpse into how the virus spreads, and more importantly, who is most at risk when public health systems fail.

Can Another Vaccination Drive Fix It?

The next phase of the response will test whether Bangladesh can move beyond broad vaccination targets to micro-level planning. Experts say success won't come from simply aiming for another 20 million doses, but from ensuring that vaccines are distributed where they're most needed.

Hussain suggested that authorities should consider extending vaccination efforts to older children in areas with immunity gaps. An anonymous epidemiologist working in Bangladesh's immunization program added that reaching children up to 15 years old may be necessary in affected regions.

But as I reflect on the scale of the tragedy, one thing becomes clear: a nation can stockpile vaccines and launch campaigns, but if the system isn't resilient enough to track who is vaccinated and who isn't, then every dose could be wasted. Public health must be about more than just distribution—it must also be about accountability.

This crisis is not just about policy failures—it's a warning to the world. It reminds us that when we rely on averages instead of action, when trust in vaccines is undermined by misinformation, and when political instability derails even basic public health programs, the price paid by innocent lives is immeasurable.

As Bangladesh moves forward with another round of vaccinations, I hope this tragedy serves as a turning point—not only for their own policies but for the global community. Because no one should have to lose a child like Mostakim or Saif to a disease that can be prevented with proper planning and execution.